✦ LIBER ✦

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective

✍ Scribed by J. D. Campbell; D. E. Spackman; S. D. Sullivan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS26 Economic Evaluation of Omalizumab

✍ Suzuki, C.; Pepe, C.; Silva, N.L. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PRS8 COSTS OF SMOKING IN SLOVAKIA FROM A

✍ J Bielik; D Tomek; M Visnansky; V Foltán; S Mesaros; P Szilagyiova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV57 COSTS OF ATRIAL FIBRILLATION IN SL

✍ J Bielik; D Tomek; M Visnansky; V Foltan; M Lednar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PRS32 Cost-Effectiveness of Omalizumab i

✍ Stern, S.; van Nooten, F.; Groot, M.; Brown, R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Economic Evaluation Of Omalizumab Add-On

✍ Suzuki, C.; Santoni, N.B.; Silva, N.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN52 COSTS OF ADVANCED GASTRIC CANCER (

✍ O Clark; EA Santos; MG Saggia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB